Back to Journals » International Journal of Nanomedicine » Volume 6

Novel formulation of a methotrexate derivative with a lipid nanoemulsion

Authors Moura J, Valduga, Tavares ER, Maranhao R, Maria, Maranhao R

Published 12 October 2011 Volume 2011:6 Pages 2285—2295


Review by Single-blind

Peer reviewer comments 2

Juliana A Moura1, Claudete J Valduga2, Elaine R Tavares1, Iara F Kretzer1,4, Durvanei A Maria3, Raul C Maranhão1,4
1Heart Institute of the Medical School Hospital, University of São Paulo; 2Bandeirante University of São Paulo; 3Butantan Institute, 4Faculty of Pharmaceutical Sciences of the University of São Paulo, São Paulo, Brazil

Background: Lipid nanoemulsions that bind to low-density lipoprotein receptors can concentrate chemotherapeutic agents in tissues with low-density lipoprotein receptor overexpression and decrease the toxicity of the treatment. The aim of this study was to develop a new formulation using a lipophilic derivative of methotrexate, ie, didodecyl methotrexate (ddMTX), associated with a lipid nanoemulsion (ddMTX-LDE).
Methods: ddMTX was synthesized by an esterification reaction between methotrexate and dodecyl bromide. The lipid nanoemulsion was prepared by four hours of ultrasonication of a mixture of phosphatidylcholine, triolein, and cholesteryloleate. Association of ddMTX with the lipid nanoemulsion was performed by additional cosonication of ddMTX with the previously prepared lipid nanoemulsion. Formulation stability was evaluated, and cell uptake, cytotoxicity, and acute animal toxicity studies were performed.
Results: The yield of ddMTX incorporation was 98% and the particle size of LDE-ddMTX was 60 nm. After 48 hours of incubation with plasma, approximately 28% ddMTX was released from the lipid nanoemulsion. The formulation remained stable for at least 45 days at 4°C. Cytotoxicity of LDE-ddMTX against K562 and HL60 neoplastic cells was higher than for methotrexate (50% inhibitory concentration [IC50] 1.6 versus 18.2 mM and 0.2 versus 26 mM, respectively), and cellular uptake of LDE-ddMTX was 90-fold higher than that of methotrexate in K562 cells and 75-fold in HL60 cells. Toxicity of LDE-ddMTX, administered at escalating doses, was higher than for methotrexate (LD50 115 mg/kg versus 470 mg/kg; maximum tolerated dose 47 mg/kg versus 94 mg/kg) in mice. However, the hematological toxicity of LDE-ddMTX was lower than for methotrexate.
Conclusion: LDE-ddMTX was stable, and uptake of the formulation by neoplastic cells was remarkably greater than of methotrexate, which resulted in markedly greater cytotoxicity. LDE-ddMTX is thus a promising formulation to be tested in future animal models of cancer or rheumatic disease, wherein methotrexate is widely used.

Keywords: nanoparticles, methotrexate, didodecyl methotrexate, drug delivery, cholesterol

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]


Other articles by this author:

Methotrexate carried in lipid core nanoparticles reduces myocardial infarction size and improves cardiac function in rats

Maranhão RC, Guido MC, de Lima AD, Tavares ER, Marques AF, Tavares de Melo MD, Nicolau JC, Salemi VMC, Kalil-Filho R

International Journal of Nanomedicine 2017, 12:3767-3784

Published Date: 17 May 2017

Simvastatin increases the antineoplastic actions of paclitaxel carried in lipid nanoemulsions in melanoma-bearing mice

Kretzer IF, Maria DA, Guido MC, Contente TC, Maranhão RC

International Journal of Nanomedicine 2016, 11:885-904

Published Date: 7 March 2016

Intra-articular methotrexate associated to lipid nanoemulsions: anti-inflammatory effect upon antigen-induced arthritis

Mello SB, Tavares ER, Bulgarelli A, Bonfá E, Maranhão RC

International Journal of Nanomedicine 2013, 8:443-449

Published Date: 14 February 2013

Reduction of atherosclerotic lesions in rabbits treated with etoposide associated with cholesterol-rich nanoemulsions

Tavares ER, Freitas FR, Diament JD, Maranhão RC

International Journal of Nanomedicine 2011, 6:2297-2304

Published Date: 12 October 2011

Readers of this article also read:

Nimodipine-loaded mixed micelles: formulation, compatibility, pharmacokinetics, and vascular irritability study

Song X, Jiang Y, Ren CJ, Sun X, Zhang Q, Gong T, Zhang ZR

International Journal of Nanomedicine 2012, 7:3689-3699

Published Date: 13 July 2012

Effect of dispersants of multi-walled carbon nanotubes on cellular uptake and biological responses

Haniu H, Saito N, Matsuda Y, Kim YA, Park KC, Tsukahara T, Usui Y, Aoki K, Shimizu M, Ogihara N, Hara K, Takanashi S, Okamoto M, Ishigaki N, Nakamura K, Kato H

International Journal of Nanomedicine 2011, 6:3295-3307

Published Date: 9 December 2011

The efficacy of mitochondrial targeting antiresistant epirubicin liposomes in treating resistant leukemia in animals

Men Y, Wang XX, Li RJ, Zhang Y, Tian W, Yao HJ, Ju RJ, Ying X, Zhou J, Li N, Zhang L, Yu Y, Lu WL

International Journal of Nanomedicine 2011, 6:3125-3137

Published Date: 2 December 2011

Translocation of PEGylated quantum dots across rat alveolar epithelial cell monolayers

Fazlollahi F, Sipos A, Kim YH, Hamm-Alvarez SF, Borok Z, Kim K-J, Crandall ED

International Journal of Nanomedicine 2011, 6:2849-2857

Published Date: 10 November 2011

Immune complement activation is attenuated by surface nanotopography

Hulander M, Lundgren A, Berglin M, Ohrlander M, Lausmaa J, Elwing H

International Journal of Nanomedicine 2011, 6:2653-2666

Published Date: 31 October 2011

Novel RGD-lipid conjugate-modified liposomes for enhancing siRNA delivery in human retinal pigment epithelial cells

Chen CW, Lu DW, Yeh MK, Shiau CY, Chiang CH

International Journal of Nanomedicine 2011, 6:2567-2580

Published Date: 26 October 2011

Microemulsion-based novel transdermal delivery system of tetramethylpyrazine: preparation and evaluation in vitro and in vivo

Zhao JH, Ji L, Wang H, Chen ZQ, Zhang YT, Liu Y, Feng NP

International Journal of Nanomedicine 2011, 6:1611-1619

Published Date: 9 August 2011

Histological study of the biodynamics of iron oxide nanoparticles with different diameters

Tsuchiya K, Nitta N, Sonoda A, Nitta-Seko A, Ohta S, Otani H, Takahashi M, Murata K, Murase K, Nohara S, Mukaisho K

International Journal of Nanomedicine 2011, 6:1587-1594

Published Date: 2 August 2011